Most Read Articles
Tristan Manalac, 06 Nov 2018
Intravenous cefiderocol thrice daily is noninferior to imipenem-cilastatin for treating complicated urinary tract infection (UTI) patients with multidrug-resistant, Gram-negative infections, according to a recent study.
01 Nov 2018
Genotype 4 hepatitis E virus infection does not appear to be correlated with acute, nontraumatic neurologic disorders, according to a recent China study.
01 Nov 2018
In patients with genotype 3 hepatitis C virus (HCV) infection and decompensated cirrhosis, the rate of achieving sustained virologic response 12 weeks after treatment (SVR12) is high with treatment regimens consisting of sofosbuvir and velpatasvir with or without ribavirin, according to the results of a phase II trial. However, the rate appears to be lower in the subgroup of patients with baseline resistance-associated substitutions in nonstructural protein 5A.
07 Nov 2018
In infants with early-life acute respiratory infection (ARI) with respiratory syncytial virus (RSV), elevated nasopharyngeal Lactobacillus levels protect against wheezing illnesses at 2 years of age, a recent study has found.

High incidence of antibiotic overuse for acute respiratory infections

Roshini Claire Anthony
02 Jul 2018

A large number of patients who present at outpatient clinics with symptoms of acute respiratory infections (ARIs) during influenza seasons are prescribed antibiotics despite not needing them, a finding that highlights the overuse of antibiotics in ARIs, a recent study showed.

“Antibiotics were likely prescribed inappropriately to a majority of the nearly 15,000 outpatients in this study who presented during influenza season with symptoms of a broadly defined ARI characterized by cough,” said the researchers.

“In addition, among those patients given diagnoses for which antibiotic therapy may be appropriate, many patients prescribed antibiotics likely did not meet criteria for antibiotic therapy based on clinician-ordered laboratory testing and clinical criteria,” they said.

Using data from the US Influenza Vaccine Effectiveness Network collected during the 2013–2014 and 2014–2015 influenza seasons, researchers identified 14,987 patients aged ≥6 months (mean age 32 years, 58 percent female) who presented at outpatient clinics with ARI. Of these, 41 percent were prescribed an antibiotic (n=6,136), with azithromycin (37 percent), amoxicillin (35 percent), amoxicillin-clavulanate (10 percent), doxycycline (5 percent), and levofloxacin (3 percent) the most commonly prescribed antibiotics.

Of the 3,306 patients with laboratory-confirmed influenza, 29 percent (n=945) were prescribed antibiotics. Antibiotic prescription was more likely among those also diagnosed with pneumonia (adjusted odds ratio [adjOR], 145.74), otitis media (adjOR, 71.77), sinusitis (adjOR, 15.34), and bronchitis (adjOR, 4.60), but not among those with pharyngitis (adjOR, 1.23). [JAMA Network Open 2018;1:e180243]

Forty-one percent of patients (n=2,522) who were prescribed an antibiotic had a diagnosis for which an antibiotic was not indicated, with 84 percent of them (n=2,106) being diagnosed with bronchitis or an upper respiratory infection (URI) due to a virus, and those with bronchitis having the highest likelihood of being prescribed an antibiotic (adjOR, 4.71).

National guidelines recommend that antibiotics be prescribed for sinusitis when severe symptoms are present for ≥3 consecutive days, and in the case of pharyngitis, following laboratory-confirmed group A streptococcus presence, said the researchers.

Of the 1,248 patients who were diagnosed with pharyngitis, 440 patients were prescribed antibiotics despite 47 percent either not undergoing testing or testing negative for group A streptococcus. Of the 1,200 patients with sinusitis and no other antibiotic-indicated condition who were prescribed antibiotics, 38 percent (n=454) had experienced symptoms for ≤3 days before presenting at the outpatient clinic.

According to the researchers, the findings in this study suggest that “many patients likely did not meet clinical criteria for antibiotic treatment as defined by national guidelines”. 

“[W]e found that a substantial proportion of antibiotic overuse was driven by prescribing for conditions for which antibiotics were not indicated, including viral URIs and acute bronchitis,” said the researchers.

“We must strengthen outpatient antibiotic stewardship efforts to eliminate antibiotic treatment for viral URIs and acute bronchitis, which our study indicates would make the largest contribution to decreasing unnecessary antibiotic prescriptions,” they said, acknowledging the potential of over- or underestimation of antibiotic use due to lack of information on prescribing strategies at certain sites.

“[Additionally], the development of sensitive and specific point-of-care testing for influenza may assist clinicians in making treatment decisions for patients with ARI during influenza season and may help to reduce unnecessary antibiotic use for influenza in outpatient settings,” said the researchers.

“Inappropriate antibiotic prescribing exposes patients to the risks of unnecessary antibiotics and represents a potential missed opportunity for patients to benefit from influenza antiviral medications. Clinicians should be encouraged to consider influenza as a clinical diagnosis during the influenza season, refrain from prescribing antibiotics in situations in which they are not recommended by guidelines, and prescribe influenza antiviral medications when indicated,” they concluded.

 

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Infectious Diseases - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Tristan Manalac, 06 Nov 2018
Intravenous cefiderocol thrice daily is noninferior to imipenem-cilastatin for treating complicated urinary tract infection (UTI) patients with multidrug-resistant, Gram-negative infections, according to a recent study.
01 Nov 2018
Genotype 4 hepatitis E virus infection does not appear to be correlated with acute, nontraumatic neurologic disorders, according to a recent China study.
01 Nov 2018
In patients with genotype 3 hepatitis C virus (HCV) infection and decompensated cirrhosis, the rate of achieving sustained virologic response 12 weeks after treatment (SVR12) is high with treatment regimens consisting of sofosbuvir and velpatasvir with or without ribavirin, according to the results of a phase II trial. However, the rate appears to be lower in the subgroup of patients with baseline resistance-associated substitutions in nonstructural protein 5A.
07 Nov 2018
In infants with early-life acute respiratory infection (ARI) with respiratory syncytial virus (RSV), elevated nasopharyngeal Lactobacillus levels protect against wheezing illnesses at 2 years of age, a recent study has found.